Quarterly Result12 Aug 2026, 08:20 pm
Sudarshan Pharma declares Q1 FY27 Unaudited Results
AI Summary
Sudarshan Pharma Industries Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved the results along with the Auditors' Limited Review Report. The company's financial statements have been prepared in accordance with Indian Accounting Standards (Ind AS). Sudarshan Pharma is engaged in the manufacturing of API, jobwork manufacturing in pharmaceuticals, and trading in chemicals and solvents, operating in a single reportable segment.
Key Highlights
- Unaudited standalone and consolidated financial results declared.
- Results for the quarter ended June 30, 2026, were approved.
- Financial statements prepared as per Ind AS.
- Company operates in a single reportable segment: speciality chemicals.
- Auditors' Limited Review Report was also submitted.
Price Impact
More from SUDARSHAN